Synaptic Targets of 9-Tetrahydrocannabinol in the Central Nervous System
Author(s) -
Alexander F. Hoffman,
Carl R. Lupica
Publication year - 2012
Publication title -
cold spring harbor perspectives in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.853
H-Index - 105
eISSN - 2472-5412
pISSN - 2157-1422
DOI - 10.1101/cshperspect.a012237
Subject(s) - cannabinoid , neuroscience , neurotransmission , cannabinoid receptor , central nervous system , tetrahydrocannabinol , neurotransmitter , δ9 tetrahydrocannabinol , delta 9 tetrahydrocannabinol , cannabinoid receptor agonists , addiction , synthetic cannabinoids , pharmacology , biology , medicine , receptor , agonist
The availability of potent synthetic agonists for cannabinoid receptors has facilitated our understanding of cannabinoid actions on synaptic transmission in the central nervous system. Moreover, the ability of these compounds to inhibit neurotransmitter release at many central synapses is thought to underlie most of the behavioral effects of cannabinoid agonists. However, despite the widespread use and misuse of marijuana, and recognition of its potential adverse psychological effects in humans, comparatively few studies have examined the actions of its primary psychoactive constituent, Δ(9)-tetrahydrocannabinol (THC), at well-defined synaptic pathways. Here we examine the recent literature describing the effects of acute and repeated THC exposure on synaptic function in several brain regions and explore the importance of these neurobiological actions of THC in drug addiction.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom